Antisocial personality and risks of cause-specific mortality: results from the Epidemiologic Catchment Area study with 27 years of follow-up.


Journal

Social psychiatry and psychiatric epidemiology
ISSN: 1433-9285
Titre abrégé: Soc Psychiatry Psychiatr Epidemiol
Pays: Germany
ID NLM: 8804358

Informations de publication

Date de publication:
May 2019
Historique:
received: 28 05 2018
accepted: 09 11 2018
pubmed: 7 12 2018
medline: 6 8 2019
entrez: 4 12 2018
Statut: ppublish

Résumé

Little is known about the effect of antisocial personality disorder (ASPD) on the risks of cause-specific mortality in the community. This study aimed to close this gap by evaluating if ASPD increases risks of cause-specific mortality in population-based residential and institutionalized samples with 27 years of follow-up. Data were collected in four metropolitan sites as part of the Epidemiologic Catchment Area (ECA) study during 1979-1983. Records were linked to the National Death Index through the end of 2007. Cox proportional hazards models adjusted for propensity weights and sample weights were fitted to estimate the effect of ASPD on the hazard of dying. 420 respondents with ASPD (median survival age 71.0 years) and 15,367 without ASPD (median survival age 84.6 years) were included in this study. Those with ASPD were more likely to die from all causes (HR = 4.46; 95% CI = 2.44-8.16), suicide (HR = 2.81; 95% CI = 1.03-7.65), malignant neoplasms (HR = 4.09; 95% CI = 2.66-6.28), chronic lower respiratory disease (HR = 5.67; 95% CI = 2.92-11.0), and human immunodeficiency virus infection (HR = 8.07; 95% CI = 2.03-32.1), but not from accidents (HR = 0.58; 95% CI = 0.17-1.93) or heart disease (HR = 1.09; 95% CI = 0.43-2.76). Our findings demonstrate that antisocial personality disorder is a strong predictor of all-cause mortality, and cause-specific mortality. Early identification, treatment, and prevention of ASPD are important public mental health initiatives that could reduce premature mortality among this vulnerable population.

Identifiants

pubmed: 30506390
doi: 10.1007/s00127-018-1628-5
pii: 10.1007/s00127-018-1628-5
doi:

Types de publication

Journal Article

Langues

eng

Pagination

617-625

Subventions

Organisme : National Institute on Drug Abuse
ID : DA026652
Organisme : National Institute on Aging
ID : R01AG052445

Références

Br Med J. 1976 Dec 25;2(6051):1525-36
pubmed: 1009386
Soc Psychiatry Psychiatr Epidemiol. 1999 May;34(5):231-42
pubmed: 10396164
BMJ. 2000 Jul 29;321(7256):263-6
pubmed: 10915126
J Abnorm Psychol. 2001 Aug;110(3):462-70
pubmed: 11502089
Lancet. 2001 Dec 22-29;358(9299):2110-2
pubmed: 11784624
Clin Psychol Rev. 2002 Feb;22(1):79-112
pubmed: 11793579
Am J Public Health Nations Health. 1957 May;47(5):601-7
pubmed: 13424810
Sex Transm Dis. 2004 Jan;31(1):8-12
pubmed: 14695951
J Clin Psychiatry. 2005 Jun;66(6):677-85
pubmed: 15960559
Curr Opin Psychiatry. 2007 Jan;20(1):17-22
pubmed: 17143077
Law Hum Behav. 2008 Dec;32(6):511-25
pubmed: 18080733
Drug Alcohol Depend. 2008 Jun 1;95 Suppl 1:S45-59
pubmed: 18243581
Drug Alcohol Depend. 2008 Jun 1;95 Suppl 1:S5-S28
pubmed: 18343607
J Clin Psychiatry. 2008 Mar;69(3):368-80
pubmed: 18348594
Ann Clin Psychiatry. 2010 May;22(2):113-20
pubmed: 20445838
Psychosomatics. 2010 Jul-Aug;51(4):289-96
pubmed: 20587756
J Psychiatr Res. 2011 Jun;45(6):835-41
pubmed: 21168156
Arch Suicide Res. 2011;15(2):93-112
pubmed: 21541857
Behav Sci Law. 2011 Sep-Oct;29(5):741-51
pubmed: 21815201
Clin Cancer Res. 2012 Apr 15;18(8):2301-8
pubmed: 22282466
Health Serv Res. 2014 Feb;49(1):284-303
pubmed: 23855598
Am J Epidemiol. 2013 Nov 1;178(9):1366-77
pubmed: 24091891
Stat Med. 2014 Mar 30;33(7):1242-58
pubmed: 24122911
Suicide Life Threat Behav. 1986 Summer;16(2):244-73
pubmed: 2428141
PLoS One. 2014 Jul 07;9(7):e100979
pubmed: 25000503
J Pers Disord. 2014 Oct;28(5):734-50
pubmed: 25248122
Can J Psychiatry. 2015 Jul;60(7):309-14
pubmed: 26175389
NIDA Res Monogr. 1989;95:401-2
pubmed: 2641008
J Epidemiol Community Health. 2016 Oct;70(10):1004-10
pubmed: 27069087
Am J Drug Alcohol Abuse. 2017 Mar;43(2):171-185
pubmed: 27532746
Pediatr Clin North Am. 2016 Oct;63(5):861-71
pubmed: 27565364
JAMA Intern Med. 2016 Dec 1;176(12):1792-1798
pubmed: 27775761
Arch Gen Psychiatry. 1984 Oct;41(10):934-41
pubmed: 6089692
Arch Gen Psychiatry. 1981 Apr;38(4):381-9
pubmed: 6260053
Public Health Rep. 1981 Jul-Aug;96(4):319-25
pubmed: 6265966
Arch Gen Psychiatry. 1984 Oct;41(10):942-8
pubmed: 6477054
Am J Psychiatry. 1996 Aug;153(8):1009-14
pubmed: 8678168
Psychosomatics. 1996 Mar-Apr;37(2):131-6
pubmed: 8742541

Auteurs

Anna Krasnova (A)

Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY, 10032, USA. ak4289@cumc.columbia.edu.

William W Eaton (WW)

Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Jack F Samuels (JF)

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH